|

Standard Chemotherapy Clinical Trials

2 actively recruiting trials

▼ -1 trial since June 2026

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Nanfang Hospital, Southern Medical University1
  • Fudan University1

Indications

  • Cancer2
  • Newly Diagnosed Acute Myeloid Leukemia With High Risk1
  • Metastatic Colorectal Cancer (CRC)1

Other2 trials

HVA vs IA/DA or VA in the Treatment of ND HR-AML
Phase 3
Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined With Local Treatment in Advanced Colorectal Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.